(Q50554400)

15 March 2018

http://europepmc.org/abstract/MED/27470327

title

The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers (English)

1 reference

15 March 2018

http://europepmc.org/abstract/MED/27470327

author

Thorsten Derlin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ralph Buchert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Ivayla Apostolova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Kilian Ego

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ingo G Steffen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Heinz Wertzel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

H Jost Achenbach

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Sandra Riedel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jens Schreiber

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Meinald Schultz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Christian Furth

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Holger Amthauer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Frank Hofheinz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Thomas Kalinski

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

28 July 2016

1 reference

15 March 2018

http://europepmc.org/abstract/MED/27470327

number of pages

14

1 reference

based on heuristic

inferred from page(s)

published in

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

2360-2373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography as a predictor of response in locally advanced non-small-cell carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

TP53 mutations in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

An automatic method for accurate volume delineation of heterogeneous tumors in PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

The quickhull algorithm for convex hulls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Intratumoral phenotypic heterogeneity as an encourager of cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Visual versus quantitative assessment of intratumor 18F-FDG PET uptake heterogeneity: prognostic value in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

EGFR mutations and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

EGF potentiation of VEGF production is cell density dependent in H292 EGFR wild type NSCLC cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Clinical impact of ki-67 labeling index in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3452-Z

Targeting the epidermal growth factor receptor in non-small cell lung cancer.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27470327

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The difference in relationship between 18F-FDG uptake and clinicopathological factors on thyroid, esophageal, and lung cancers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27470327

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-016-3452-Z

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470327%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference